• HyperScribe T7 High Yield RNA Synthesis Kit: Workflow & CRIS

  2026-05-19

  Unlock rapid, high-yield RNA synthesis for demanding applications such as CRISPR gene editing and RNA therapeutics with the HyperScribe T7 High Yield RNA Synthesis Kit. Discover protocol insights, troubleshooting strategies, and lessons from cutting-edge breast cancer research to maximize RNA quality and experimental efficiency.

• 10 mM dNTP Mixture: Precision and Trafficking in DNA Synthes

  2026-05-18

  Explore how the 10 mM dNTP mixture enables high-fidelity DNA synthesis and impacts intracellular nucleotide delivery. This article provides a unique perspective by integrating core biochemical parameters with new insights from lipid nanoparticle trafficking research.

• Nicotinamide Riboside Chloride (NIAGEN): Enabling Reproducib

  2026-05-18

  Explore how Nicotinamide Riboside Chloride (NIAGEN) drives reproducibility in metabolic dysfunction research and neurodegenerative disease models. This article uniquely analyzes assay design and practical integration strategies for NAD+ modulation, grounded in recent breakthroughs.

• Isoprinosine (SKU C4417): Reliable Immunomodulator for Viral

  2026-05-17

  This article provides a scenario-driven, evidence-based guide for biomedical researchers seeking reproducible immunomodulation and direct antiviral effects in cell-based assays. We examine Isoprinosine (inosine pranobex, SKU C4417) as supplied by APExBIO, focusing on its demonstrated reliability, workflow compatibility, and quantitative performance data relevant to viral infection models, including HHV-1. Practical insights and protocol parameters are integrated throughout for optimal experimental outcomes.

• T0070907: Nanomolar PPARγ Antagonist for Pathway Dissection

  2026-05-16

  T0070907 is a potent, selective PPARγ antagonist with 1 nM IC50, enabling high-precision inhibition of PPARγ signaling and adipogenesis. Its covalent mechanism disrupts coactivator binding and promotes corepressor recruitment, providing a robust tool for dissecting transcriptional repression and cell cycle effects. APExBIO supplies T0070907 (A4301) for advanced research applications in metabolic and cancer biology.

• Arachidonic Acid Supplementation Accelerates Vaccine Immunit

  2026-05-15

  This study demonstrates that dietary arachidonic acid (ARA) significantly enhances the speed and magnitude of humoral immune responses to rabies vaccination in both mice and humans. By elucidating the cAMP-PKA axis and prostaglandin I2 as key mediators, the research provides a mechanistic foundation for dietary fatty acid modulation as a strategy to improve vaccine efficacy.

• Dual-Function Anti-Inflammatory Stent Suppresses Tracheal Re

  2026-05-15

  A recent study by Zhao et al. introduces an airway stent integrating anti-inflammatory and anti-angiogenic agents, effectively reducing tracheal in-stent restenosis in a rabbit model. The stent addresses the overlooked issue of excessive vascularization and provides a new avenue for modulating the tracheal microenvironment to improve stent durability and patient outcomes.

• ISRIB (trans-isomer): Rewiring Memory Research via ISR Modul

  2026-05-14

  Discover how ISRIB (trans-isomer), a next-generation PERK inhibitor, is redefining translational memory research by bridging mechanistic insight and strategic experimental design. Drawing from recent molecular neurobiology findings, this article provides actionable guidance for ER stress research, highlights ISRIB’s unique advantages, and sets the agenda for future studies in cognitive enhancement and neurodegenerative disease models.

• Murine RNase Inhibitor: Redefining RNA Integrity in Translat

  2026-05-14

  This article explores the mechanistic underpinnings and strategic value of Murine RNase Inhibitor (SKU K1046) for translational RNA workflows. Framing the challenge of RNA degradation in light of new post-transcriptional regulatory findings, it delivers actionable guidance for researchers seeking robust, oxidation-resistant RNA protection—especially in advanced applications like oocyte maturation studies, real-time RT-PCR, and cDNA synthesis. The article uniquely bridges recent mechanistic research on RNA modifications with the practical demands of modern molecular biology, and contextualizes APExBIO’s Murine RNase Inhibitor as a transformative tool for reproducibility and rigor.

• NAT10-Driven ac4C RNA Modification Regulates Oocyte Maturati

  2026-05-13

  This study identifies NAT10-mediated N4-acetylcytidine (ac4C) as a key mRNA modification influencing post-transcriptional regulation during mouse oocyte maturation. Functional knockdown of NAT10 impairs meiotic progression, highlighting ac4C’s pivotal role and expanding our understanding of epitranscriptomic control in reproductive biology.

• Angiotensin (1-7): Advanced Pathophysiology and Translationa

  2026-05-13

  Explore the multifaceted roles of Angiotensin (1-7) in cellular signaling, anti-inflammatory action, and viral pathogenesis. This article delivers an in-depth analysis of Angiotensin (1-7), including cutting-edge insight into its influence on SARS-CoV-2 spike protein binding and practical guidance for research applications.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-12

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), can significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. This unexpected cross-domain interaction highlights a potential link between the renin-angiotensin system and viral entry mechanisms, with implications for both COVID-19 pathogenesis and future therapeutic strategies.

• CCR7–Notch1 Crosstalk Sustains Breast Cancer Stemness: Key I

  2026-05-12

  Boyle et al. (2017) uncover a direct signaling interplay between CCR7 and Notch1 pathways that maintains stem-like cell populations in MMTV-PyMT mammary tumors. This mechanistic insight into cancer stem cell regulation has significant implications for targeted breast cancer therapy development.

• EZH2 Inhibition Targets HPV-Driven Cervical Cancer: Insights

  2026-05-11

  This study demonstrates that EZH2 inhibitors, particularly EPZ-6438, suppress proliferation and induce apoptosis in HPV-associated cervical cancer cells by modulating key oncogenic and tumor suppressor pathways. The findings highlight the therapeutic potential of targeting the polycomb repressive complex 2 (PRC2) pathway in HPV-driven malignancies with lower toxicity than conventional chemotherapy.

• Population PK Modeling of Adefovir as an OAT1 Probe in Trans

  2026-05-11

  This study applies population pharmacokinetic (popPK) modeling to clarify how adefovir behaves as a component in multi-transporter phenotyping cocktails. The findings refine understanding of OAT1-mediated drug interactions and confirm adefovir’s specificity and reliability in transporter phenotyping clinical studies.

556 records 18/38 page Previous Next First page 上5页 1617181920 下5页 Last page